How come nobody discuses new fda regulatory trial endpoints that are being allowed on ongoing cell therapy clinical trials.
No need for placebo control if it looks like obvious efficacy. Use of real world data. Its actually a game changer in the business because clinical trials will be much cheaper. Anyway one of you smart guys should elaborate on the new guidance coming forward
Cheers friends
- Forums
- ASX - By Stock
- New fda guidelines for approvoal of new therapies
How come nobody discuses new fda regulatory trial endpoints that...
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MSB (ASX) to my watchlist
(20min delay)
|
|||||
Last
$1.01 |
Change
0.035(3.61%) |
Mkt cap ! $1.107B |
Open | High | Low | Value | Volume |
99.5¢ | $1.01 | 99.0¢ | $851.1K | 849.8K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
17 | 40083 | $1.01 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.01 | 112380 | 13 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
14 | 34343 | 1.005 |
17 | 108722 | 1.000 |
19 | 121306 | 0.995 |
13 | 184695 | 0.990 |
6 | 71842 | 0.985 |
Price($) | Vol. | No. |
---|---|---|
1.010 | 111220 | 13 |
1.015 | 74993 | 15 |
1.020 | 67483 | 14 |
1.025 | 56912 | 8 |
1.030 | 50481 | 9 |
Last trade - 10.49am 04/07/2024 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham, CEO
James Graham
CEO
Previous Video
Next Video
SPONSORED BY The Market Online